NCT07740486
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
- Locations
-
Not specified
Clinical trial condition
Neoplasms, Plasma Cell
Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.
2,604 public trials
547 recruiting studies
Neoplasms, Plasma Cell trial results
Not Yet Recruiting
A Phase 1 Study of UB-VV500 With Rapamycin in Relapsed/Refractory Multiple Myeloma
NCT07735546
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
Not specified
NCT07735637
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Research Site Tampa, Florida, United States
- Research Site Atlanta, Georgia, United States
- Research Site Atlanta, Georgia, United States
- Research Site Chicago, Illinois, United States
NCT07728188
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- University of Arizona Cancer Center /ID# 285339 Tucson, Arizona, United States
- Toi Clinical Research - Whittier /ID# 284462 Cerritos, California, United States
- University of California Los Angeles /ID# 282444 Los Angeles, California, United States
- University Of Colorado - Anschutz Medical Campus /ID# 283478 Aurora, Colorado, United States
NCT07727668
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Icahn School of Medicine at Mount Sinai New York, United States
Not Yet Recruiting
A Study of KIV-318 Injection in Patients With BCMA-Positive Relapsed/Refractory Multiple Myeloma
NCT07726160
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin, China
Not Yet Recruiting
Low-Dose TBI Plus CAR T-Cell Therapy for Relapsed/Refractory DLBCL and Multiple Myeloma
NCT07725406
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +23 more
- Locations
-
- Weill Cornell Medicine/NewYork-Presbyterian Hospital New York, United States
Not Yet Recruiting
Prospective Evaluation of Subcutaneous Administration of Daratumumab by the FreedomEDGE® Infusion System
NCT07721350
- Conditions
- Amyloidosis, Behavior, Blood Protein Disorders, +21 more
- Locations
-
- Hôpital Lyon-Sud Pierre-Bénite, France
Not Yet Recruiting
TAlquetamab and BeLantamab Mafodotin in Relapsed/Refractory Multiple Myeloma (TaBleMM)
NCT07720843
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
- Locations
-
Not specified
Not Yet Recruiting
INfections in Patients Treated With CAR-T
NCT07713511
- Conditions
- B-Cell Non-Hodgkin Lymphoma, Blood Protein Disorders, Bloodstream Infections, +29 more
- Locations
-
- IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy